What's in Insight Therapeutics, LLC's pipeline?

Insight Therapeutics, LLC has 7 drugs in our index: 7 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Insight Therapeutics, LLC's portfolio?

Top competitors by shared drug class: GlaxoSmithKline, Serum Institute of India Pvt. Ltd., ANRS, Emerging Infectious Diseases, Il-Yang Pharm. Co., Ltd., Sanofi Pasteur, a Sanofi Company.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/insight-therapeutics-llc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Insight Therapeutics, LLC — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Insight Therapeutics, LLC pipeline: 7 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

7 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
HD Fluzone Vaccine	HD Fluzone Vaccine	marketed
adjuvanted trivalent influenza vaccine	adjuvanted trivalent influenza vaccine	marketed	vaccine		Immunology
Free Vaccine	Free Vaccine	marketed
SD Vaccine	SD Vaccine	marketed
Recombinant Influenza Vaccine	Recombinant Influenza Vaccine	marketed
SD Fluzone Vaccine	SD Fluzone Vaccine	marketed	inactivated influenza vaccine		Immunology
HD Vaccine	HD Vaccine	marketed	Therapeutic vaccine	Huntingtin protein (HTT)	Neurology

Therapeutic area mix

Immunology · 2
Neurology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

GlaxoSmithKline · 3 shared drug classes
Serum Institute of India Pvt. Ltd. · 2 shared drug classes
ANRS, Emerging Infectious Diseases · 2 shared drug classes
Il-Yang Pharm. Co., Ltd. · 2 shared drug classes
Sanofi Pasteur, a Sanofi Company · 2 shared drug classes
Seqirus · 2 shared drug classes
Merck Sharp & Dohme LLC · 2 shared drug classes
Sinovac Biotech Co., Ltd · 2 shared drug classes

Subscribe to ongoing alerts

Every new pipeline event for Insight Therapeutics, LLC:

Cite this brief

Drug Landscape (2026). Insight Therapeutics, LLC — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/insight-therapeutics-llc. Accessed 2026-05-17.